Similar articles for PMID: 28750598

Year	Number of Results
1999	2
2001	2
2002	1
2003	1
2004	5
2005	1
2006	3
2007	2
2008	4
2009	3
2010	2
2011	2
2012	3
2013	3
2014	3
2015	8
2016	10
2017	13
2018	8
2019	24
2020	44
2021	39
2022	92
2023	40
2024	5

1

Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.

Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH. Bissell BD, et al. J Intensive Care Med. 2019 Sep;34(9):761-765. doi: 10.1177/0885066617716396. Epub 2017 Jul 28. J Intensive Care Med. 2019. PMID: 28750598

2

Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.

Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J. Musallam N, et al. Ann Pharmacother. 2018 Aug;52(8):733-739. doi: 10.1177/1060028018765187. Epub 2018 Mar 21. Ann Pharmacother. 2018. PMID: 29560736

3

Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.

Taylor A, Jones T, Forehand CC, Smith SE, Dykes H, Newsome AS. Taylor A, et al. J Pharm Pract. 2022 Dec;35(6):879-885. doi: 10.1177/08971900211015080. Epub 2021 May 12. J Pharm Pract. 2022. PMID: 33977793 Free PMC article.

4

Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.

Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. Hammond DA, et al. J Intensive Care Med. 2019 Oct;34(10):805-810. doi: 10.1177/0885066617714209. Epub 2017 Jun 15. J Intensive Care Med. 2019. PMID: 28618919

5

Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.

Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR. Sacha GL, et al. Pharmacotherapy. 2018 Mar;38(3):319-326. doi: 10.1002/phar.2082. Epub 2018 Feb 8. Pharmacotherapy. 2018. PMID: 29328496

6

Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.

Haan BJ, Cadiz ML, Natavio AM. Haan BJ, et al. Ann Pharmacother. 2020 Mar;54(3):213-218. doi: 10.1177/1060028019882035. Epub 2019 Oct 18. Ann Pharmacother. 2020. PMID: 31625395

7

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators. Gordon AC, et al. JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485. JAMA. 2016. PMID: 27483065 Free article. Clinical Trial.

8

A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.

Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP. Daley MJ, et al. Ann Pharmacother. 2013 Mar;47(3):301-10. doi: 10.1345/aph.1R442. Epub 2013 Feb 27. Ann Pharmacother. 2013. PMID: 23447481

9

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Russell JA, et al. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373. N Engl J Med. 2008. PMID: 18305265 Free article. Clinical Trial.

10

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M. Morelli A, et al. Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10. Crit Care. 2009. PMID: 19664253 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

261 results

Results by year